Nutex Health, Inc. (NUTX) Q4 FY25 Earnings Call

Strong full-year growth and liquidity contrast with arbitration-related revenue volatility and weak reported fourth-quarter profitability.

Q4 FY25 results, source: company transcript and SEC filings
QuarterQ4 FY25
Call date2026-03-07
Length58 minutes
EPS$1.61
Revenue$267.8M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

All NUTX earnings ยท Back to NUTX overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.